# Clinical Comparative Study Aiming to Evaluate Postoperative Effect of Using Intrathecal Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Lower Limb Vascular Surgeries on Pain Intensity, Analgesic Requirement and Shivering. Patients and Methods After Approval of Medical Institution

> **NCT07035223** · PHASE4 · COMPLETED · sponsor: **Nashwa Ahmed** · enrollment: 40 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** 4 µg dexmedetomidine in 0.5 mL of normal saline intrathecal (dexmedetomidine 100 µg/mL will be diluted in 12.5 ml preservative-fr
- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT07035223
- **Lead sponsor:** Nashwa Ahmed
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-08
- **Primary completion:** 2025-05-08
- **Final completion:** 2025-05-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07035223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07035223, "Clinical Comparative Study Aiming to Evaluate Postoperative Effect of Using Intrathecal Dexmedetomidine and Fentanyl as an Adjuvant to Heavy Bupivacaine in Lower Limb Vascular Surgeries on Pain Intensity, Analgesic Requirement and Shivering. Patients and Methods After Approval of Medical Institution". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07035223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*